Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Decreased EMILIN2 correlates to metabolism phenotype and poor prognosis of ovarian cancer.

Journal of biochemistry - 25 Jul 2022

Tang Xiaojian, Li Fengli

Abstract excerpt

This study aimed to explore the function and related mechanisms of elastin microfibril interfacer 2 (EMILIN2) in ovarian cancer. First, the expression level of EMILIN2 was detected in patient tissues and its correlation with overall survival rate was analysed. Then, EMILIN2 was overexpressed in ovarian cancer cell lines to observe its function and effect on Warburg effect. By detecting its promoter region...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cell Line, Tumor
Share to DNA Methylation
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Glycoproteins

Share to Ovarian Neoplasms

Share to Phenotype

Share to Prognosis

Share to Tumor Suppressor Protein p53

Source

Identifiers

PMID: 35588228
DOI: 10.1093/jb/mvac046

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Decreased EMILIN2 correlates to metabolism phenotype and poor prognosis of ovarian cancer.PMID 35588228Read ↗

Silencing of MICAL-L2 suppresses malignancy of ovarian cancer by inducing mesenchymal-epithelial transition.Semantic proximity Read ↗

Highly expressed NRSN2 is related to malignant phenotype in ovarian cancer.Semantic proximity Read ↗

Diagnostic Exome Sequencing Identifies a Novel Gene, EMILIN1, Associated with Autosomal-Dominant Hereditary Connective Tissue Disease.Semantic proximity Read ↗

LMO2 promotes tumor cell invasion and metastasis in basal-type breast cancer by altering actin cytoskeleton remodelingSemantic proximity Read ↗

Dysregulation of fibulin-5 and matrix metalloproteases in epithelial ovarian cancerSemantic proximity Read ↗

ST14 interacts with TMEFF1 and is a predictor of poor prognosis in ovarian cancer.Semantic proximity Read ↗

EMILIN-1 Deficiency Induces Elastogenesis and Vascular Cell DefectsSemantic proximity Read ↗

Pathophysiological Roles of Actin-Binding Scaffold Protein, EzrinSemantic proximity Read ↗

ESM1 enhances fatty acid synthesis and vascular mimicry in ovarian cancer by utilizing the PKM2-dependent warburg effect within the hypoxic tumor microenvironmentSemantic proximity Read ↗

A prognostic gene signature in advanced ovarian cancer reveals a microfibril-associated protein (MAGP2) as a promoter of tumor cell survival and angiogenesisSemantic proximity Read ↗

Lipocalin 2 promotes breast cancer progression.Semantic proximity Read ↗

PFN2, a novel marker of unfavorable prognosis, is a potential therapeutic target involved in esophageal squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.